Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma
Glioblastoma is an immunologically ‘cold’ tumor, which are characterized by absent or minimal numbers of tumor-infiltrating lymphocytes (TILs). For those tumors that have been invaded by lymphocytes, they are profoundly exhausted and ineffective. While many immunotherapy approaches seek to reinvigor...
Guardado en:
Autores principales: | Kirit Singh, Kelly M. Hotchkiss, Kisha K. Patel, Daniel S. Wilkinson, Aditya A. Mohan, Sarah L. Cook, John H. Sampson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8aef5234162f41c9be3e1d253db29419 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Lin Tang, et al.
Publicado: (2021) -
Galectins in Glioma: Current Roles in Cancer Progression and Future Directions for Improving Treatment
por: Samy Ajarrag, et al.
Publicado: (2021) -
Encapsulated n-Butylidenephthalide Efficiently Crosses the Blood–Brain Barrier and Suppresses Growth of Glioblastoma
por: Lin YL, et al.
Publicado: (2020) -
The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
por: Wang YH, et al.
Publicado: (2017) -
Antibody Drug Conjugates in Glioblastoma – Is There a Future for Them?
por: Sagun Parakh, et al.
Publicado: (2021)